320 related articles for article (PubMed ID: 28341272)
1. Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia.
Mace ML; Gravesen E; Nordholm A; Hofman-Bang J; Secher T; Olgaard K; Lewin E
Kidney Int; 2017 Jul; 92(1):165-178. PubMed ID: 28341272
[TBL] [Abstract][Full Text] [Related]
2. Regulation of fibroblast growth factor 23 production in bone in uremic rats.
Saji F; Shiizaki K; Shimada S; Okada T; Kunimoto K; Sakaguchi T; Hatamura I; Shigematsu T
Nephron Physiol; 2009; 111(4):p59-66. PubMed ID: 19339809
[TBL] [Abstract][Full Text] [Related]
3. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia.
Hassan A; Durlacher K; Silver J; Naveh-Many T; Levi R
Am J Physiol Renal Physiol; 2016 Feb; 310(3):F217-21. PubMed ID: 26311115
[TBL] [Abstract][Full Text] [Related]
4. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.
Spichtig D; Zhang H; Mohebbi N; Pavik I; Petzold K; Stange G; Saleh L; Edenhofer I; Segerer S; Biber J; Jaeger P; Serra AL; Wagner CA
Kidney Int; 2014 Jun; 85(6):1340-50. PubMed ID: 24402093
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.
Saji F; Shigematsu T; Sakaguchi T; Ohya M; Orita H; Maeda Y; Ooura M; Mima T; Negi S
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1212-7. PubMed ID: 20739393
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model.
Sugiura H; Matsushita A; Futaya M; Teraoka A; Akiyama KI; Usui N; Nagano N; Nitta K; Tsuchiya K
PLoS One; 2018; 13(3):e0191706. PubMed ID: 29518087
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast Growth Factor (FGF) 23 Regulates the Plasma Levels of Parathyroid Hormone In Vivo Through the FGF Receptor in Normocalcemia, But Not in Hypocalcemia.
Mace ML; Gravesen E; Nordholm A; Olgaard K; Lewin E
Calcif Tissue Int; 2018 Jan; 102(1):85-92. PubMed ID: 29063159
[TBL] [Abstract][Full Text] [Related]
8. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
Carrillo-López N; Panizo S; Alonso-Montes C; Román-García P; Rodríguez I; Martínez-Salgado C; Dusso AS; Naves M; Cannata-Andía JB
Kidney Int; 2016 Jul; 90(1):77-89. PubMed ID: 27165819
[TBL] [Abstract][Full Text] [Related]
9. Mutant FGF23 prevents the progression of chronic kidney disease but aggravates renal osteodystrophy in uremic rats.
Kusano K; Saito H; Segawa H; Fukushima N; Miyamoto K
J Nutr Sci Vitaminol (Tokyo); 2009 Apr; 55(2):99-105. PubMed ID: 19436134
[TBL] [Abstract][Full Text] [Related]
10. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
Stubbs J; Liu S; Quarles LD
Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
Durlacher-Betzer K; Hassan A; Levi R; Axelrod J; Silver J; Naveh-Many T
Kidney Int; 2018 Aug; 94(2):315-325. PubMed ID: 29861060
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast Growth Factor-23-A Potential Uremic Toxin.
Kuczera P; Adamczak M; Wiecek A
Toxins (Basel); 2016 Dec; 8(12):. PubMed ID: 27941640
[TBL] [Abstract][Full Text] [Related]
14. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
[TBL] [Abstract][Full Text] [Related]
15. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats.
Bisson SK; Ung RV; Picard S; Valade D; Agharazii M; Larivière R; Mac-Way F
J Bone Miner Metab; 2019 Mar; 37(2):212-223. PubMed ID: 29603070
[TBL] [Abstract][Full Text] [Related]
16. Circadian rhythm of activin A and related parameters of mineral metabolism in normal and uremic rats.
Nordholm A; Egstrand S; Gravesen E; Mace ML; Morevati M; Olgaard K; Lewin E
Pflugers Arch; 2019 Aug; 471(8):1079-1094. PubMed ID: 31236663
[TBL] [Abstract][Full Text] [Related]
17. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
[TBL] [Abstract][Full Text] [Related]
18. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
Graciolli FG; Neves KR; Barreto F; Barreto DV; Dos Reis LM; Canziani ME; Sabbagh Y; Carvalho AB; Jorgetti V; Elias RM; Schiavi S; Moysés RMA
Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623
[TBL] [Abstract][Full Text] [Related]
19. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.
Nagano N; Miyata S; Abe M; Kobayashi N; Wakita S; Yamashita T; Wada M
Kidney Int; 2006 Feb; 69(3):531-7. PubMed ID: 16395276
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis.
Fan Y; Bi R; Densmore MJ; Sato T; Kobayashi T; Yuan Q; Zhou X; Erben RG; Lanske B
FASEB J; 2016 Jan; 30(1):428-40. PubMed ID: 26428657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
